Ajax-Loading

Johnson & Johnson - Total Revenue

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Revenue" stands at 92.15 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2023.

Johnson & Johnson's third quarter result of 23.99 Billion USD for the item "Total Revenue" represents an increase of 1.05 percent compared to it's second quarter result.

Also, Johnson & Johnson's third quarter result of 23.99 Billion USD for the item "Total Revenue" represents an increase of 6.77 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 92.15 Billion USD for the item "Total Revenue" represents an increase of 1.68 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.08 percent compared to the value the year prior.
The 1 year change in percent is 5.08.
The 3 year change in percent is -4.05.
The 5 year change in percent is 13.97.
The 10 year change in percent is 30.68.

The Serie's long term average value is 79.65 Billion United States Dollars. It's latest available value, on 09/30/2025, is 15.69 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2012, to it's latest available value, on 09/30/2025, is +42.04%.
The Serie's change in percent from it's maximum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is -4.05%.

Total Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Revenue905,699,262,464.00
LogoAbbVie Inc - Total Revenue399,570,305,024.00
LogoRoche Holding AG - Total Revenue317,433,206,677.55
LogoAstraZeneca PLC - Total Revenue280,205,508,085.11
LogoNovartis AG - Total Revenue255,096,620,580.91